⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent childhood rhabdomyosarcoma

Every month we try and update this database with for recurrent childhood rhabdomyosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesNCT01048892
Adrenocortical ...
Gastrointestina...
Kidney Cancer
Neuroblastoma
Retinoblastoma
Sarcoma
Seneca Valley v...
cyclophosphamid...
laboratory biom...
pharmacological...
3 Years - 21 YearsChildren's Oncology Group
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory RhabdomyosarcomaNCT01222715
Adult Rhabdomyo...
Childhood Alveo...
Childhood Pleom...
Childhood Rhabd...
Previously Trea...
Recurrent Adult...
Recurrent Child...
Bevacizumab
Cyclophosphamid...
Laboratory Biom...
Temsirolimus
Vinorelbine Tar...
- 29 YearsNational Cancer Institute (NCI)
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaNCT00006102
Brain and Centr...
Lymphoma
Neuroblastoma
Retinoblastoma
Sarcoma
Unspecified Chi...
becatecarin
- 21 YearsNational Cancer Institute (NCI)
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With RhabdomyosarcomaNCT01626170
Alveolar Childh...
Embryonal Child...
Previously Trea...
Previously Untr...
Recurrent Child...
laboratory biom...
- Children's Oncology Group
Retrospective Study in FFPE Samples From Younger Patients With RhabdomyosarcomaNCT06040229
Alveolar Childh...
Embryonal Child...
Recurrent Child...
1 Year - 18 YearsShandong First Medical University
Ex Vivo Drug Sensitivity Testing and Mutation ProfilingNCT03860376
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Chil...
Refractory Chil...
Refractory Chil...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Chro...
1 Day - 21 YearsFlorida International University
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With RhabdomyosarcomaNCT01626170
Alveolar Childh...
Embryonal Child...
Previously Trea...
Previously Untr...
Recurrent Child...
laboratory biom...
- Children's Oncology Group
Biomarker in Tumor Tissue Samples From Patients With RhabdomyosarcomaNCT01365962
Sarcoma
gene expression...
immunohistochem...
laboratory biom...
mass spectromet...
- Children's Oncology Group
Cryosurgery in Treating Patients With Soft Tissue SarcomaNCT00002863
Sarcoma
chemotherapy
conventional su...
cryosurgery
- University of Southern California
Exatecan Mesylate in Treating Children With Relapsed or Refractory RhabdomyosarcomaNCT00055939
Sarcoma
exatecan mesyla...
- Daiichi Sankyo
Biomarkers in Samples From Young Patients With Soft Tissue SarcomaNCT01342783
Sarcoma
DNA analysis
RNA analysis
mutation analys...
nucleic acid se...
laboratory biom...
- 18 YearsChildren's Oncology Group
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue SarcomaNCT00919269
Adult Rhabdomyo...
Childhood Desmo...
Chordoma
Desmoid-Type Fi...
Metastatic Chil...
Non-Metastatic ...
Previously Trea...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Rhabdomyosarcom...
Stage I Adult S...
Stage II Adult ...
Stage III Adult...
Stage IV Adult ...
Untreated Child...
Cytology Specim...
Laboratory Biom...
- 50 YearsChildren's Oncology Group
Studying Protein Expression in Tissue Samples From Younger Patients With RhabdomyosarcomaNCT01609803
Alveolar Childh...
Embryonal Child...
Previously Trea...
Previously Untr...
Recurrent Child...
laboratory biom...
- 21 YearsChildren's Oncology Group
Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid TumorsNCT00002543
Brain and Centr...
Lymphoma
Neuroblastoma
Sarcoma
Unspecified Chi...
gallium nitrate
- 21 YearsNational Cancer Institute (NCI)
Retrospective Study in FFPE Samples From Younger Patients With RhabdomyosarcomaNCT06040229
Alveolar Childh...
Embryonal Child...
Recurrent Child...
1 Year - 18 YearsShandong First Medical University
Retrospective Study in FFPE Samples From Younger Patients With RhabdomyosarcomaNCT06040229
Alveolar Childh...
Embryonal Child...
Recurrent Child...
1 Year - 18 YearsShandong First Medical University
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System TumorsNCT01158300
Brain and Centr...
VEGF inhibitor ...
3 Years - 21 YearsPediatric Brain Tumor Consortium
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerNCT01132547
Cancer
cyproheptadine ...
placebo
2 Years - 21 YearsUniversity of South Florida
Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaNCT00025363
Alveolar Childh...
Embryonal Child...
Embryonal-botry...
Previously Trea...
Recurrent Child...
vincristine sul...
irinotecan hydr...
cyclophosphamid...
doxorubicin hyd...
ifosfamide
etoposide
tirapazamine
filgrastim
sargramostim
pharmacological...
pharmacogenomic...
laboratory biom...
- 20 YearsNational Cancer Institute (NCI)
Protein Expression in Samples From Young Patients With RhabdomyosarcomaNCT01426945
Sarcoma
protein express...
immunohistochem...
laboratory biom...
- Children's Oncology Group
Studying Protein Expression in Tissue Samples From Younger Patients With RhabdomyosarcomaNCT01609803
Alveolar Childh...
Embryonal Child...
Previously Trea...
Previously Untr...
Recurrent Child...
laboratory biom...
- 21 YearsChildren's Oncology Group
Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid TumorsNCT00002543
Brain and Centr...
Lymphoma
Neuroblastoma
Sarcoma
Unspecified Chi...
gallium nitrate
- 21 YearsNational Cancer Institute (NCI)
Cryosurgery in Treating Patients With Soft Tissue SarcomaNCT00002863
Sarcoma
chemotherapy
conventional su...
cryosurgery
- University of Southern California
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesNCT01048892
Adrenocortical ...
Gastrointestina...
Kidney Cancer
Neuroblastoma
Retinoblastoma
Sarcoma
Seneca Valley v...
cyclophosphamid...
laboratory biom...
pharmacological...
3 Years - 21 YearsChildren's Oncology Group
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of TumorsNCT00070109
Previously Trea...
Recurrent Child...
Recurrent Child...
Recurrent Ewing...
Peripheral Prim...
trabectedin
pharmacological...
12 Months - 50 YearsChildren's Oncology Group
Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaNCT00025363
Alveolar Childh...
Embryonal Child...
Embryonal-botry...
Previously Trea...
Recurrent Child...
vincristine sul...
irinotecan hydr...
cyclophosphamid...
doxorubicin hyd...
ifosfamide
etoposide
tirapazamine
filgrastim
sargramostim
pharmacological...
pharmacogenomic...
laboratory biom...
- 20 YearsNational Cancer Institute (NCI)
Biomarker in Tumor Tissue Samples From Patients With RhabdomyosarcomaNCT01365962
Sarcoma
gene expression...
immunohistochem...
laboratory biom...
mass spectromet...
- Children's Oncology Group
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)NCT03155620
Advanced Malign...
Ann Arbor Stage...
Ann Arbor Stage...
Histiocytic Sar...
Juvenile Xantho...
Langerhans Cell...
Malignant Gliom...
Recurrent Child...
Recurrent Epend...
Recurrent Ewing...
Recurrent Gliom...
Recurrent Hepat...
Recurrent Lange...
Recurrent Malig...
Recurrent Malig...
Recurrent Medul...
Recurrent Neuro...
Recurrent Non-H...
Recurrent Osteo...
Recurrent Perip...
Recurrent Prima...
Recurrent Rhabd...
Recurrent Soft ...
Refractory Ewin...
Refractory Glio...
Refractory Hepa...
Refractory Lang...
Refractory Mali...
Refractory Mali...
Refractory Medu...
Refractory Neur...
Refractory Non-...
Refractory Oste...
Refractory Peri...
Refractory Prim...
Refractory Rhab...
Refractory Rhab...
Rhabdoid Tumor
Stage III Osteo...
Stage III Soft ...
Stage IV Osteos...
Stage IV Soft T...
Stage IVA Osteo...
Stage IVB Osteo...
Wilms Tumor
Biopsy
Biospecimen Col...
Bone Marrow Asp...
Bone Scan
Computed Tomogr...
Ensartinib
Erdafitinib
Laboratory Biom...
Larotrectinib S...
Magnetic Resona...
Mutation Carrie...
Olaparib
Palbociclib
Pharmacological...
Positron Emissi...
Radionuclide Im...
Samotolisib
Selpercatinib
Selumetinib Sul...
Tazemetostat
Tipifarnib
Ulixertinib
Vemurafenib
X-Ray Imaging
12 Months - 21 YearsNational Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: